REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish.
body weight
feeding
fish
glucose
growth
lipids
metabolism
nr1d1
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
08 Mar 2022
08 Mar 2022
Historique:
received:
07
02
2022
revised:
02
03
2022
accepted:
03
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
9
4
2022
Statut:
epublish
Résumé
REV-ERBα (
Identifiants
pubmed: 35328345
pii: ijms23062921
doi: 10.3390/ijms23062921
pmc: PMC8955992
pii:
doi:
Substances chimiques
Nuclear Receptor Subfamily 1, Group D, Member 1
0
Pyrrolidines
0
RNA, Messenger
0
SR9009
0
Thiophenes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Nature. 2012 Mar 29;485(7396):62-8
pubmed: 22460951
J Endocrinol. 2006 Mar;188(3):513-20
pubmed: 16522731
Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R193-206
pubmed: 22031781
Sci Rep. 2017 Oct 30;7(1):14383
pubmed: 29085009
J Comp Physiol B. 2016 Dec;186(8):1009-1021
pubmed: 27277972
BMC Genomics. 2016 Dec 8;17(1):1008
pubmed: 27931190
Nat Commun. 2020 Jun 17;11(1):3071
pubmed: 32555162
Science. 2015 Jun 26;348(6242):1488-92
pubmed: 26044300
Nat Med. 2013 Aug;19(8):1039-46
pubmed: 23852339
J Neuroendocrinol. 2020 Feb;32(2):e12833
pubmed: 31957097
Nat Prod Res. 2020 Nov;34(22):3226-3230
pubmed: 30663351
Fish Physiol Biochem. 2020 Jun;46(3):891-907
pubmed: 32072342
J Biol Chem. 2015 Feb 13;290(7):4367-82
pubmed: 25544291
Nat Rev Mol Cell Biol. 2015 Nov;16(11):678-89
pubmed: 26490400
Mar Biotechnol (NY). 2018 Dec;20(6):750-768
pubmed: 30182177
FEBS Lett. 2008 Jan 9;582(1):19-25
pubmed: 17765229
PLoS One. 2014 Jun 12;9(6):e99172
pubmed: 24921252
J Mol Endocrinol. 2018 May;60(4):R171-R199
pubmed: 29467140
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25869-25879
pubmed: 32989157
PLoS One. 2014 Sep 03;9(9):e106739
pubmed: 25184355
Mol Endocrinol. 1995 Dec;9(12):1666-78
pubmed: 8614403
Nature. 1998 May 7;393(6680):72-6
pubmed: 9590691
Curr Pharm Des. 2011;17(4):320-4
pubmed: 21375499
PLoS Biol. 2009 Sep;7(9):e1000181
pubmed: 19721697
Science. 2007 Dec 14;318(5857):1786-9
pubmed: 18006707
Endocrinology. 2012 Feb;153(2):592-601
pubmed: 22166979
Gen Comp Endocrinol. 2018 Feb 1;257:13-28
pubmed: 28185936
Science. 2011 Mar 11;331(6022):1315-9
pubmed: 21393543
Nat Rev Drug Discov. 2014 Mar;13(3):197-216
pubmed: 24577401
Animals (Basel). 2021 Mar 03;11(3):
pubmed: 33802373
Nat Struct Mol Biol. 2007 Dec;14(12):1207-13
pubmed: 18037887
Nat Commun. 2014 Dec 23;5:5759
pubmed: 25536025
Nature. 2008 Dec 18;456(7224):997-1000
pubmed: 19037247
Trends Endocrinol Metab. 2014 Nov;25(11):586-92
pubmed: 25066191
Nature. 2012 Mar 29;485(7396):123-7
pubmed: 22460952
Theranostics. 2020 Mar 4;10(9):4168-4182
pubmed: 32226546
Front Neurosci. 2017 Jun 26;11:354
pubmed: 28694769
Biochem Biophys Res Commun. 2008 Apr 18;368(4):955-8
pubmed: 18280802
Mol Endocrinol. 2014 Apr;28(4):490-8
pubmed: 24552589
Diabetes Obes Metab. 2015 Sep;17 Suppl 1:106-14
pubmed: 26332975
Mol Cell Biol. 2008 Apr;28(7):2213-20
pubmed: 18227153
PLoS One. 2016 May 19;11(5):e0156367
pubmed: 27195801
Pharmacol Res. 2019 Mar;141:310-318
pubmed: 30639375
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Lipid Res. 2002 Dec;43(12):2172-9
pubmed: 12454280
Cell. 2014 May 8;157(4):858-68
pubmed: 24813609
Mol Cell Endocrinol. 2019 Nov 1;497:110437
pubmed: 31054868
Pharmacol Biochem Behav. 2019 Jun;181:101-109
pubmed: 31054945
Int J Mol Sci. 2016 May 30;17(6):
pubmed: 27249000
Horm Behav. 2020 Jan;117:104609
pubmed: 31647920
FASEB J. 2012 Aug;26(8):3321-35
pubmed: 22562834
PLoS Biol. 2020 Mar 13;18(3):e3000435
pubmed: 32168317
Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12147-12152
pubmed: 31127047
Int J Obes (Lond). 2016 May;40(5):824-32
pubmed: 26607039